People

Overview

Christine Ryu-Naya is an experienced antitrust lawyer whose practice focuses on U.S. and international merger clearance, counseling, investigations, and antitrust litigation. She has counseled clients through all stages of the merger review process, including representing parties before the Department of Justice and Federal Trade Commission in connection with complex and vigorously challenged transactions, negotiating and complying with government information requests, coordinating antitrust filings in foreign jurisdictions, and negotiating and implementing consent orders.

Ms. Ryu-Naya counsels clients on a variety of business issues, including interlocking directorates, data privacy, integration planning, non-solicitation agreements, and the design and implementation of compliance programs. Her practice also includes representing companies in internal competition-related investigations and in connection with investigations launched by federal antitrust enforcement agencies. She has helped with favorable business outcomes and motions to dismiss for corporations facing complex and contentious litigation matters in federal district court.

Prior to joining Baker Botts, Ms. Ryu-Naya was an associate at another large international law firm.

Admission & Affiliations

  • District of Columbia Bar
  • New York State Bar
  • United States District Courts for the Southern and Eastern Districts of New York
  • J.D., University of Virginia School of Law 2012
    Articles Editor, Virginia Journal of Law and Technology
  • B.A., History, Cornell University 2009

Experience

  • Represented Merck & Co. in its acquisitions of OncoImmune and ArQule, as well as various potential acquisitions.
  • Represented leading mid-market private equity fund, American Industrial Partners, in connection with its acquisitions of Moly-Cop, Goss International, and numerous other businesses.
  • Represented defendant, Eaton Corporation, in complaint action alleging monopolization, exclusionary conduct, fraud, unfair competition, and unjust enrichment brought by an indirect purchaser in federal court in Missouri.
  • Represented Boehringer Ingelheim in its $12.6 billion asset swap with Sanofi.
  • Represented Rockwater Energy Solutions in its merger with Select Energy Solutions.
  • Represented private company client in negotiating an FTC Part III administrative proceeding.
  • Represented MeadWestvaco Corporation in receiving worldwide clearance for its $16 billion merger with RockTenn Corporation.
  • Represented Novartis in its $20 billion oncology and vaccines transaction with GlaxoSmithKline.


01 February 2024 Webinar Q1 2024 Healthcare and Pharma Update
December 2022 Client Updates Intellectual Property Report

Awards and Community

Recognized by Washington D.C. Super Lawyers as a "Rising Star," 2019 & 2020

Recognized in Best Lawyers' Inaugural "Ones to Watch" List, 2020